Akero Therapeutics (NASDAQ:AKRO) Downgraded by Morgan Stanley to Equal Weight

Akero Therapeutics} stock has undergone multiple analysts rating changes in the recent past.  Akero Therapeutics Downgraded by Morgan Stanley on 10/19/2021. In a note to investors, the firm issued a new rating of Equal Weight. The analysts previously had rating of Overweight.

View More Akero Therapeutics (NASDAQ:AKRO) Downgraded by Morgan Stanley to Equal Weight

Akero Therapeutics (NASDAQ:AKRO) Downgraded by Zacks Investment Research to Sell

Akero Therapeutics} stock has undergone multiple analysts rating changes in the recent past.  Akero Therapeutics Downgraded by Zacks Investment Research on 10-12-21. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

View More Akero Therapeutics (NASDAQ:AKRO) Downgraded by Zacks Investment Research to Sell